Article: Clozapine-induced myocarditis: recognizing a potentially fatal adverse reaction

A 46-year-old man with a history of paranoid schizophrenia was admitted with a recurrence of psychotic symptoms. Improvement was noted after the initiation of clozapine. After 2 weeks of clozapine therapy, chest pressure and abnormal cardiac biomarkers (in the presence of a normal coronary angiogram) raised suspicion of myocarditis. That diagnosis was confirmed by means of cardiac magnetic resonance imaging. Discontinuation of the clozapine led to resolution of the cardiac symptoms. Clozapine-induced myocarditis is rare and can be missed for lack of specific clinical findings. In order to prevent disease progression and a possibly fatal outcome, early recognition of the condition and prompt discontinuation of clozapine are necessary.

Citing Articles

Toward a broader view of mechanisms of drug cardiotoxicity.

Mamoshina P, Rodriguez B, Bueno-Orovio A Cell Rep Med. 2021; 2(3):100216.

PMID: 33763655 PMC: 7974548. DOI: 10.1016/j.xcrm.2021.100216.

Isolated nausea and vomiting as the cardinal presenting symptoms of clozapine-induced myocarditis: a case report.

van der Horst M, van Houwelingen F, Luykx J BMC Psychiatry. 2020; 20(1):568.

PMID: 33246443 PMC: 7694895. DOI: 10.1186/s12888-020-02955-9.

Successful Clozapine Re-Challenge After Suspected Clozapine-Induced Myocarditis.

Hosseini S, Skrzypcak B, Yasaei R, Abdijadid S, Joolhar F, Win T Am J Case Rep. 2020; 21:e926507.

PMID: 33137026 PMC: 7647933. DOI: 10.12659/AJCR.926507.

Clozapine-Induced Cardiotoxicity Presenting as Sepsis: A Case Report and Literature Review.

Khalid M, Jegede O, Gayam V, Yang Y, Shrestha B, Mandal A Case Rep Med. 2019; 2019:3435108.

PMID: 31049067 PMC: 6462315. DOI: 10.1155/2019/3435108.

Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

de Berardis D, Rapini G, Olivieri L, Di Nicola D, Tomasetti C, Valchera A Ther Adv Drug Saf. 2018; 9(5):237-256.

PMID: 29796248 PMC: 5956953. DOI: 10.1177/2042098618756261.

References

1.

Hagg S, Spigset O, Bate A, Soderstrom T . Myocarditis related to clozapine treatment. J Clin Psychopharmacol. 2001; 21(4):382-8. DOI: 10.1097/00004714-200108000-00005. View

2.

Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H . Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004; 109(10):1250-8. DOI: 10.1161/01.CIR.0000118493.13323.81. View

3.

Elman I, Goldstein D, Eisenhofer G, Folio J, Malhotra A, Adler C . Mechanism of peripheral noradrenergic stimulation by clozapine. Neuropsychopharmacology. 1999; 20(1):29-34. DOI: 10.1016/S0893-133X(98)00047-5. View

4.

Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D . Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005; 45(11):1815-22. DOI: 10.1016/j.jacc.2004.11.069. View

5.

Manu P, Sarpal D, Muir O, Kane J, Correll C . When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature. Schizophr Res. 2011; 134(2-3):180-6. PMC: 3318984. DOI: 10.1016/j.schres.2011.10.014. View

6.

Haas S, Hill R, Krum H, Liew D, Tonkin A, Demos L . Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003. Drug Saf. 2006; 30(1):47-57. DOI: 10.2165/00002018-200730010-00005. View

7.

Kilian J, Kerr K, Lawrence C, Celermajer D . Myocarditis and cardiomyopathy associated with clozapine. Lancet. 1999; 354(9193):1841-5. DOI: 10.1016/s0140-6736(99)10385-4. View

8.

Cooper L, Baughman K, Feldman A, Frustaci A, Jessup M, Kuhl U . The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure.... J Am Coll Cardiol. 2007; 50(19):1914-31. DOI: 10.1016/j.jacc.2007.09.008. View

9.

Friedrich M, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper L . Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009; 53(17):1475-87. PMC: 2743893. DOI: 10.1016/j.jacc.2009.02.007. View

10.

Liu P, Yan A . Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation. J Am Coll Cardiol. 2005; 45(11):1823-5. DOI: 10.1016/j.jacc.2005.03.002. View

Clozapine-induced Myocarditis: Recognizing a Potentially Fatal Adverse Reaction